Role of VP Shunts in Communicating Hydrocephalus

Pathophysiology and Indications

Progressive ventriculomegaly is the most typical indication warranting surgical treatment among hydrocephalus patients, with surgical intervention becoming necessary for symptomatic individuals 1, 2
Most patients with macrocephaly may stabilize spontaneously, but surgical intervention becomes necessary for symptomatic individuals 1

ETV has emerged as an alternative to VP shunts for treating communicating hydrocephalus, with recent evidence suggesting that ETV has a lower complication rate than VP shunts 1, 2
Studies have demonstrated higher symptom resolution rates with ETV compared to traditional VP shunt placement 1
The superiority of ETV has been established in certain patient populations, particularly in pediatric achondroplasia patients 1, 2

Both CSF shunts and ETV demonstrate equivalent overall outcomes in many clinical scenarios (Level II evidence, moderate clinical certainty) 3, 4
When adjusted for patient age and hydrocephalus etiology, early failure is higher for ETV than for shunt placement, but after 3 months, the ETV failure rate becomes lower than that for shunt surgery 5
In achondroplasia patients, surgical intervention for hydrocephalus results in favorable outcomes, with complete symptom resolution achieved in 75% of cases 1
VP shunts in achondroplasia patients are often associated with recurrent failures and multiple revisions 1

Confirm diagnosis of communicating hydrocephalus through imaging (MRI with contrast) 6
Evaluate for progressive ventriculomegaly and symptoms 1
For patients with suitable anatomy, ETV should be considered first due to lower long-term complication rates 1, 2
For patients with unsuitable anatomy for ETV, VP shunt is recommended 1

Anatomical challenges may limit ETV feasibility in some patients with communicating hydrocephalus 1
Technical challenges include narrow prepontine space, absence of discernible interpeduncular cisterns, and risk of injury to the distal basilar artery complex 1
Continuous monitoring of vital signs and mean arterial pressure is crucial in children with VP shunts, with specific targets based on age 7
Regular documentation of neurological status, including pupillary size and reaction, is essential during follow-up of shunted patients 7